Phenylmethyl O-(N-Acetyl-α-neuraminosyl)-3-O-(β-D-galactopyranosyl)-4-[2-(acetylamino)-2-deoxy]-β-D-glucopyranoside
- $750 - $2200
- Product name: Phenylmethyl O-(N-Acetyl-α-neuraminosyl)-3-O-(β-D-galactopyranosyl)-4-[2-(acetylamino)-2-deoxy]-β-D-glucopyranoside
- CAS: 176166-22-6
- MF: C32H48N2O19
- MW: 764.72552
- EINECS:
- MDL Number:
- Synonyms:Phenylmethyl O-(N-Acetyl-α-neuraminosyl)-3-O-(β-D-galactopyranosyl)-4-[2-(acetylamino)-2-deoxy]-β-D-glucopyranoside;Phenylmethyl O-(N-Acetyl-α-neuraminosyl)-3-O-(β-D-galactopyranosyl)-4-[2-(acetylamino)-2-deoxy]-β-D-glucopyranoside;β-D-Glucopyranoside, phenylmethyl O-(N-acetyl-α-neuraminosyl)-(2→3)-O-β-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy- (9CI)
2 prices
Selected condition:
Brand
- Medical Isotopes, Inc.
- TRC
Package
- 1mg
- 10mg
- ManufacturerMedical Isotopes, Inc.
- Product number61170
- Product descriptionPhenylmethylO-(N-Acetyl-α-neuraminosyl)-3-O-(β-D-galactopyranosyl)-4-[2-(acetylamino)-2-deoxy]-β-D-glucopyranoside
- Packaging1mg
- Price$750
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP335765
- Product descriptionPhenylmethylO-(N-Acetyl-α-neuraminosyl)-3-O-(β-D-galactopyranosyl)-4-[2-(acetylamino)-2-deoxy]-β-D-glucopyranoside
- Packaging10mg
- Price$2200
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Medical Isotopes, Inc. | 61170 | PhenylmethylO-(N-Acetyl-α-neuraminosyl)-3-O-(β-D-galactopyranosyl)-4-[2-(acetylamino)-2-deoxy]-β-D-glucopyranoside | 1mg | $750 | 2021-12-16 | Buy |
TRC | P335765 | PhenylmethylO-(N-Acetyl-α-neuraminosyl)-3-O-(β-D-galactopyranosyl)-4-[2-(acetylamino)-2-deoxy]-β-D-glucopyranoside | 10mg | $2200 | 2021-12-16 | Buy |
Properties
Boiling point :1177.2±65.0 °C(Predicted)
Density :1.59±0.1 g/cm3(Predicted)
pka :1.92±0.70(Predicted)
Density :1.59±0.1 g/cm3(Predicted)
pka :1.92±0.70(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|